Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry-Reference-Cited by-同舟云学术

Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry

Published:2018-07-18 Issue:1 Volume:5 Page:35-42
ISSN:2058-5225
Container-title:European Heart Journal - Quality of Care and Clinical Outcomes
language:en
Short-container-title:

Author:

An Yoshimori¹,Ogawa Hisashi¹,Yamashita Yugo¹,Ishii Mitsuru¹,Iguchi Moritake¹,Masunaga Nobutoyo¹,Esato Masahiro²,Tsuji Hikari³,Wada Hiromichi⁴,Hasegawa Koji⁴,Abe Mitsuru¹,Lip Gregory Y H⁵⁶,Akao Masaharu¹

Affiliation:

1. Department of Cardiology, National Hospital Organization Kyoto Medical Center, 1-1, Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto, Japan

2. Department of Arrhythmia, Ijinkai Takeda General Hospital, Kyoto, Japan

3. Tsuji Clinic, Kyoto, Japan

4. Division of Translational Research, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

5. Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK

6. Department of Clinical Medicine, Aalborg Thrombosis Research Unit, Aalborg University, Aalborg, Denmark

Funder

Boehringer Ingelheim

Bayer Healthcare

Pfizer

Bristol-Myers Squibb

Astellas Pharma

AstraZeneca

Daiichi Sankyo

Novartis Pharma

MSD

Sanofi-Aventis and Takeda Pharmaceutical

Japan Agency for Medical Research and Development

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Health Policy

Link

http://academic.oup.com/ehjqcco/article-pdf/5/1/35/27287116/qcy033.pdf

Reference24 articles.

1. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study;Benjamin;Circulation,1998

2. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007;Piccini;Circ Cardiovasc Qual Outcomes,2012

3. Causes of death in anticoagulated patients with atrial fibrillation;Gómez-Outes;J Am Coll Cardiol,2016

4. Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study;Marijon;Circulation,2013

5. Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF;Pokorney;J Am Heart Assoc,2016

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypertrophic Cardiomyopathy Predicts Thromboembolism and Heart Failure in Patients With Nonvalvular Atrial Fibrillation　― A Prospective Analysis From the Hokuriku-Plus AF Registry ―;Circulation Journal;2023-11-24

2. B-Type Natriuretic Peptide Level for Atrial Fibrillation Ablation　― Is It a Wonderful Fortune Teller or a Mirror Reflecting Reality? ―;Circulation Journal;2023-11-24

3. Should atrial fibrillation be considered a vascular disease? The need for a comprehensive vascular approach;Expert Review of Cardiovascular Therapy;2023-11-02

4. Echocardiographic multiparameter assessment for patients with heart failure with preserved ejection fraction and atrial fibrillation;CARDIOVASC J AFR;2023

5. Utility of left ventricular ejection fraction in atrial fibrillation patients without pre‐existing heart failure;ESC Heart Failure;2023-08-21